These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 11553618

  • 1. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.
    Uversky VN, Li J, Fink AL.
    J Biol Chem; 2001 Nov 23; 276(47):44284-96. PubMed ID: 11553618
    [Abstract] [Full Text] [Related]

  • 2. Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: implications for Parkinson's disease.
    Uversky VN, Li J, Bower K, Fink AL.
    Neurotoxicology; 2002 Oct 23; 23(4-5):527-36. PubMed ID: 12428725
    [Abstract] [Full Text] [Related]

  • 3. Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins.
    Uversky VN, Li J, Souillac P, Millett IS, Doniach S, Jakes R, Goedert M, Fink AL.
    J Biol Chem; 2002 Apr 05; 277(14):11970-8. PubMed ID: 11812782
    [Abstract] [Full Text] [Related]

  • 4. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.
    Li J, Uversky VN, Fink AL.
    Biochemistry; 2001 Sep 25; 40(38):11604-13. PubMed ID: 11560511
    [Abstract] [Full Text] [Related]

  • 5. Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease.
    Uversky VN, Li J, Fink AL.
    FEBS Lett; 2001 Jul 06; 500(3):105-8. PubMed ID: 11445065
    [Abstract] [Full Text] [Related]

  • 6. Evidence for a partially folded intermediate in alpha-synuclein fibril formation.
    Uversky VN, Li J, Fink AL.
    J Biol Chem; 2001 Apr 06; 276(14):10737-44. PubMed ID: 11152691
    [Abstract] [Full Text] [Related]

  • 7. Forcing nonamyloidogenic beta-synuclein to fibrillate.
    Yamin G, Munishkina LA, Karymov MA, Lyubchenko YL, Uversky VN, Fink AL.
    Biochemistry; 2005 Jun 28; 44(25):9096-107. PubMed ID: 15966733
    [Abstract] [Full Text] [Related]

  • 8. Role of protein-water interactions and electrostatics in alpha-synuclein fibril formation.
    Munishkina LA, Henriques J, Uversky VN, Fink AL.
    Biochemistry; 2004 Mar 23; 43(11):3289-300. PubMed ID: 15023080
    [Abstract] [Full Text] [Related]

  • 9. Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro.
    Cohlberg JA, Li J, Uversky VN, Fink AL.
    Biochemistry; 2002 Feb 05; 41(5):1502-11. PubMed ID: 11814343
    [Abstract] [Full Text] [Related]

  • 10. Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations.
    Uversky VN, Lee HJ, Li J, Fink AL, Lee SJ.
    J Biol Chem; 2001 Nov 23; 276(47):43495-8. PubMed ID: 11590163
    [Abstract] [Full Text] [Related]

  • 11. Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments.
    Cole NB, Murphy DD, Lebowitz J, Di Noto L, Levine RL, Nussbaum RL.
    J Biol Chem; 2005 Mar 11; 280(10):9678-90. PubMed ID: 15615715
    [Abstract] [Full Text] [Related]

  • 12. Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T.
    Li J, Uversky VN, Fink AL.
    Neurotoxicology; 2002 Oct 11; 23(4-5):553-67. PubMed ID: 12428728
    [Abstract] [Full Text] [Related]

  • 13. Certain metals trigger fibrillation of methionine-oxidized alpha-synuclein.
    Yamin G, Glaser CB, Uversky VN, Fink AL.
    J Biol Chem; 2003 Jul 25; 278(30):27630-5. PubMed ID: 12754258
    [Abstract] [Full Text] [Related]

  • 14. Effect of metals on herbicides-alpha-synuclein association: a possible factor in neurodegenerative disease studied by capillary electrophoresis.
    André C, Truong TT, Robert JF, Guillaume YC.
    Electrophoresis; 2005 Sep 25; 26(17):3256-64. PubMed ID: 16143978
    [Abstract] [Full Text] [Related]

  • 15. Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes.
    Munishkina LA, Phelan C, Uversky VN, Fink AL.
    Biochemistry; 2003 Mar 11; 42(9):2720-30. PubMed ID: 12614167
    [Abstract] [Full Text] [Related]

  • 16. The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils.
    Zhu M, Rajamani S, Kaylor J, Han S, Zhou F, Fink AL.
    J Biol Chem; 2004 Jun 25; 279(26):26846-57. PubMed ID: 15096521
    [Abstract] [Full Text] [Related]

  • 17. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
    Conway KA, Harper JD, Lansbury PT.
    Nat Med; 1998 Nov 25; 4(11):1318-20. PubMed ID: 9809558
    [Abstract] [Full Text] [Related]

  • 18. Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein.
    Golts N, Snyder H, Frasier M, Theisler C, Choi P, Wolozin B.
    J Biol Chem; 2002 May 03; 277(18):16116-23. PubMed ID: 11850416
    [Abstract] [Full Text] [Related]

  • 19. Methionine oxidation, alpha-synuclein and Parkinson's disease.
    Glaser CB, Yamin G, Uversky VN, Fink AL.
    Biochim Biophys Acta; 2005 Jan 17; 1703(2):157-69. PubMed ID: 15680224
    [Abstract] [Full Text] [Related]

  • 20. The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation.
    Zhu M, Li J, Fink AL.
    J Biol Chem; 2003 Oct 10; 278(41):40186-97. PubMed ID: 12885775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.